RSS

Infliximab

According to data and analytics company, GlobalData, new real-world evidence will support the use of a biosimilar treatment for Crohn’s disease (CD), leading to a boost in the biosimilar market value. more

Analysis

The BGMA has welcomed the publication by the NICE of an implementation pack to support the introduction of biosimilar versions of Infliximab. more

News